Alcon AG (Switzerland) Insiders
| ALC Stock | CHF 79.46 0.58 0.74% |
Alcon AG employs about 24 K people. The company is managed by 10 executives with a total tenure of roughly 56000 years, averaging almost 5600.0 years of service per executive, having 2400.0 employees per reported executive. Recap of Alcon AG's management performance can provide insight into the venture performance.
| David Endicott Insider CEO Director |
| Margaret Buckley Insider Chief Officer |
Alcon |
Alcon AG Management Team Effectiveness
The company has return on total asset (ROA) of 0.0217 % which means that it generated a profit of $0.0217 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0295 %, meaning that it generated $0.0295 on every $100 dollars invested by stockholders. Alcon AG's management efficiency ratios could be used to measure how well Alcon AG manages its routine affairs as well as how well it operates its assets and liabilities.Alcon AG Workforce Comparison
Alcon AG is number one stock in number of employees category among its peers. The total workforce of Medical Instruments & Supplies industry is presently estimated at about 258,706. Alcon AG holds roughly 24,000 in number of employees claiming about 9% of all equities under Medical Instruments & Supplies industry.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.11. Alcon AG Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Alcon AG Price Series Summation is a cross summation of Alcon AG price series and its benchmark/peer.
Alcon AG Notable Stakeholders
An Alcon AG stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Alcon AG often face trade-offs trying to please all of them. Alcon AG's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Alcon AG's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| David Endicott | CEO Director | Profile | |
| Margaret Buckley | Chief Officer | Profile | |
| Kimberly Martin | VP Officer | Profile | |
| Arthur MD | Ex Director | Profile | |
| SueJean Lin | VP Officer | Profile | |
| Timothy Stonesifer | Chief Officer | Profile | |
| Royce Bedward | Gen VP | Profile | |
| Laurent Attias | Strategy, Devel | Profile | |
| Michael Ball | Ex Chairman | Profile | |
| Franck Leveiller | Head VP | Profile |
About Alcon AG Management Performance
The success or failure of an entity such as Alcon AG often depends on how effective the management is. Alcon AG management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Alcon management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Alcon management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Alcon, Inc. develops and manufactures eye care products for eye care professionals and their patients. operates independently of Novartis AG as of April 9, 2019. ALCON N operates under Medical Instruments Supplies classification in Switzerland and is traded on Switzerland Exchange. It employs 20000 people.
Please note, the imprecision that can be found in Alcon AG's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Alcon AG. Check Alcon AG's Beneish M Score to see the likelihood of Alcon AG's management manipulating its earnings.
Alcon AG Workforce Analysis
Traditionally, organizations such as Alcon AG use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Alcon AG within its industry.Alcon AG Manpower Efficiency
Return on Alcon AG Manpower
| Revenue Per Employee | 345.5K | |
| Revenue Per Executive | 829.1M | |
| Net Income Per Employee | 15.7K | |
| Net Income Per Executive | 37.6M |
Additional Tools for Alcon Stock Analysis
When running Alcon AG's price analysis, check to measure Alcon AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alcon AG is operating at the current time. Most of Alcon AG's value examination focuses on studying past and present price action to predict the probability of Alcon AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alcon AG's price. Additionally, you may evaluate how the addition of Alcon AG to your portfolios can decrease your overall portfolio volatility.